This inventor holds 3 USPTO granted patents. Top assignee: Kyocera Corporation. Active years: 2003-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2026
Title: Junji Ikeda: Innovator in Biomedical Implant Materials
Introduction
Junji Ikeda is a notable inventor hailing from Gamo-gun, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative implant materials. His work focuses on enhancing the performance and reliability of biomedical implants.
Latest Patents
Ikeda holds a patent for a biomedical implant material and the method of producing the same. This invention provides a biomedical implant material that comprises a substrate made of a ceramic material. It features a first coating layer formed on the surface of the substrate through a low-thermal impact coating process. Additionally, a second coating layer is formed on the first coating layer via a metallic layer created by a thermal spraying process. This innovative approach prevents cracks from occurring in the ceramic substrate and ensures sufficient bonding strength between the thermal-sprayed layer of titanium or similar materials and the ceramic substrate. He has 1 patent to his name.
Career Highlights
Junji Ikeda is associated with Kyocera Corporation, where he applies his expertise in materials science to develop advanced biomedical solutions. His work at Kyocera has positioned him as a key player in the field of biomedical implants.
Collaborations
Ikeda has collaborated with notable colleagues, including Iwao Noda and Takefumi Nakanishi. These partnerships have contributed to the advancement of innovative technologies in the biomedical sector.
Conclusion
Junji Ikeda's contributions to biomedical implant materials demonstrate his commitment to innovation and excellence in engineering. His patented work continues to influence the development of safer and more effective biomedical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
